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Amphiphilic Polyanhydride Films Promote Neural
Stem Cell Adhesion and Differentiation
Latrisha K. Petersen, Ph.D.,1 Jisun Oh, Ph.D.,2 Donald S. Sakaguchi, Ph.D.,2
Surya K. Mallapragada, Ph.D.,1 and Balaji Narasimhan, Ph.D.1
Several challenges currently exist for rational design of functional tissue engineering constructs within the host,
which include appropriate cellular integration, avoidance of bacterial infections, and low inflammatory stimu-
lation. This work describes a novel class of biodegradable, amphiphilic polyanhydrides with many desirable
protein-material and cell-material attributes capable of confronting these challenges. The biocompatible am-
phiphilic polymer films were shown to release laminin in a stable and controlled manner, promote neural cell
adhesion and differentiation, and evade inflammatory responses of the immune system. Using high-throughput
approaches, it was shown that polymer chemistry plays an integral role in controlling cell–film interactions,
which suggests that these polyanhydrides can be tailored to achieve the desired cell adhesion and differentiation
while minimizing immune recognition. These findings have important implications for development of en-
gineered constructs to regulate differentiation and target the growth of transplanted cells in stem cell-based
therapies to treat nervous system disorders.
Introduction
Biodegradable polymeric scaffolds and implantcoatings have been used widely to facilitate implant
tissue integration while defending against bacterial bur-
dens.1,2 Polymers provide the ability to mechanically and
chemically control cellular integration through structure and
surface functionalization with or without controlled release
of biological cues (growth factors, adhesion molecules,
etc.).1,2 Functionalization or controlled release properties can
also be used to inhibit bacterial growth and adhesion.1,3
Proper cellular integration, limiting fibrosis (adhesion of fi-
broblasts which results in poor implant binding), and low
inflammatory stimulation are essential for polymer implant
or scaffold viability within the host.1,2
Many current polymer systems lack the ability to provide
controlled release of biologically active molecules, and some
fragile proteins may lose their function when encapsulated in
biodegradable polymers such as poly(lactide-co-glycolide)
(PLGA).4–6 In addition, with bulk eroding polymers such as
PLGA, the structural integrity of the device may be com-
promised because once the molar mass is low enough, there
is a rapid loss of mechanical properties.2,7,8 In contrast, sur-
face eroding polymers are characterized by a slow loss of
mechanical stability over time, which would reduce the
possibility of scaffold collapse before new tissue formation
and integration with the host.2 In addition to mechanical
integrity, it is important for the polymer construct to evade
clearance by the immune system and avoid an inflammatory
response. Inflammation and immune activation can lead to
the buildup of fibroblasts, which inhibit tissue integration
and implant acceptance by the host.1,2 Stimulation of the
innate immune system can occur through mechanisms such
as the binding of pathogen-associated molecular patterns to
pattern recognition receptors on the surface of immune cells
and/or complement activation. Thus, it would be desirable
to design surface eroding polymeric constructs for tissue
engineering that are capable of modulating the inflammatory
response of the immune system to provide a controlled en-
vironment conducive to cellular growth and regeneration.
Polyanhydrides have been studied extensively as vehicles
for protein and vaccine delivery over the past decade9–27;
however, little work to date has investigated their use in
tissue engineering applications. These surface eroding poly-
mers are biologically inert, nontoxic, and nonmutagenic and
are capable of providing sustained release kinetics of en-
capsulated proteins.11,13,14,17,19,20,24 Additionally, polyanhy-
drides have been shown to stabilize a wide range of
biologically active molecules, such as F1-V (vaccine antigen
for pneumonic plague), PA (vaccine antigen for anthrax),
lipocalin-2, ovalbumin, lysozyme, and tetanus toxoid
(vaccine antigen for tetanus).11,13–15,17,19,21,24,28 Specifically,
polyanhydrides based upon 1,6-bis( p-carboxyphenoxy)hex-
ane (CPH) and 1,8-bis( p-carboxyphenoxy)-3,6-dioxaoctane
(CPTEG) have been studied extensively because of their
amphiphilic properties, controlled protein release and pro-
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tein stabilization capabilities, immune modulation, and
cellular compatibility.9,22,23,25–27 These polymers can also be
functionalized to target-specific cellular receptors.12 Upon
degradation, CPTEG:CPH copolymers result in small chan-
ges in pH (7.6–7.1) unlike other systems (i.e., PLGA), which
result in much greater decreases in pH to as low as 2.6.19,29–32
These properties make this polymer system a promising
candidate for tissue engineering applications combined with
targeted delivery and/or surface functionalization.
The focus of this work was to investigate amphiphilic
CPTEG:CPH polyanhydride copolymer films for their ability
to control protein release and stability while providing a
nontoxic, immune-stealthy, and cell conducive environment
for neural stem cell growth and adhesion. The findings in-
dicate that CPTEG:CPH copolymer films provide an ideal
nonfouling substrate for cellular exclusion, but with the in-
corporation of extracellular matrix proteins, cellular adhe-
sion is restored. Additionally, by altering the chemistry of the
polymer, this polymer system was capable of modulating
immune stimulation, protein release kinetics, and cellular
differentiation. These studies were performed using a high-
throughput, combinatorial approach, which enabled the
rapid assessment of protein–polymer and cell–polymer
interactions.
Materials and Methods
Polymer library synthesis and characterization
CPH and CPTEG monomers were synthesized as de-
scribed previously.33,34 CPTEG:CPH copolymer film libraries
were synthesized via a melt polycondensation reaction in
multiwell substrates utilizing a robotic deposition apparatus,
as reported previously.20,21,23,34 Copolymer chemistry and
molecular weight were determined by proton nuclear mag-
netic resonance (1H NMR) spectroscopy using a Varian VXR
300MHz spectrometer (Varian, Inc.). Gel permeation chro-
matography (GPC) was also used to measure the polymer
molecular weight with a Waters GPC chromatograph.
Fabrication of protein encapsulated
and blank (no protein) film libraries
Blank and laminin-loaded combinatorial film libraries
were fabricated from the polymer libraries as described
previously.20,23 Briefly, laminin and methylene chloride were
added to the polymer film library and sonicated, and the
protein/polymer solution in each well was separately dis-
pensed onto glass coverslips (1.5mg polymer/coverslip at
1% laminin loading [for a total of 15 mg of laminin])
and allowed to dry resulting in a protein-encapsulated film
library.
High-throughput protein release
After encapsulation of laminin into the polymer films, the
films were placed in a 24-well polystyrene plate, and 2mL
PBS buffer (0.1mM, pH 7.6) added to each well. The plate
was sealed to prevent evaporation and incubated in a hori-
zontal shaker at 37C and 100 rpm for the duration of the
experiment. At incremental time points, samples of the su-
pernatant were removed and replaced with fresh PBS buffer
to maintain constant sink conditions. Laminin concentration
in each sample was determined with the microbicinchoninic
acid assay (Thermo Scientific), which was carried out in
triplicate. The mass of protein released at each time point
was normalized by the total mass of protein encapsulated
into the film, which is presented as cumulative mass fraction
of released laminin.20
Culture and stimulation of dendritic cells
All procedures involving animals were conducted in ac-
cordance with procedures that were approved by the Iowa
State University Institutional Animal Care and Use Com-
mittee. Bone marrow-derived dendritic cells (BMDCs) were
isolated from C57BL/6 mice (ISU Laboratory Animal Re-
source Facility) and cultured using a previously developed
method.12,22,23,26 BMDCs were grown in DC culture medium
(RPMI containing 1% L-glutamine, 1% penicillin–streptomycin
solution, 2%HEPES, 0.5% gentamycin, 0.1% b-mercaptoethanol,
and 10% heat inactivated fetal bovine serum) supplemented
with granulocyte macrophage colony-stimulating factor
(10 ng/mL). After 9 days of culture, DCs were incubated for
48 h with the different treatments: polymer films [poly
(CPTEG), 75:25 CPTEG:CPH, 50:50 CPTEG:CPH, 25:75
CPTEG:CPH, and poly(CPH), at a concentration of 1.5mg/
coverslip], no polymer (NP; negative control), and lipo-
polysaccharide (LPS; 200 ng/mL, positive control).
Cell surface marker expression
The expression of cell surface markers, including CD11c,
CD86, CD40, MHC I, and MHC II, was assessed with flow
cytometry as described elsewhere.23,25 The samples were run
on a Becton-Dickinson FACSCanto flow cytometer and an-
alyzed with FlowJo (TreeStar, Inc.).
Cytokine production
After incubation with the treatments, supernatants from
DC cultures were collected and assayed for cytokines, TNF-a,
IL-6, and IL-12, using the Luminex Multiplex assay.23,25
MTT cellular toxicity assay
The CellTiter 96 Non-Radioactive Cell Proliferation Assay
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) (Promega) was used to determine the cellular vi-
ability of DCs incubated with the polymer films for 48 h. The
DCs were incubated with the MTT assay for 3 h and the cell
viability was quantified by measuring the optical density.
Culture and stimulation of human neural
progenitor cells
Human neural stem/progenitor cells (hNPCs), isolated
from 16- to 18-week fetal cortex, were purchased from
Lonza.35 The hNPCs were cultured as neurospheres in main-
tenance medium (a proprietary medium, Bulletkit; Lonza)
further supplemented with 10 ng/mL human recombinant
basic fibroblast growth factor (Promega, Madison, WI) and
20 ng/mL epidermal growth factor (Gibco).35 This mainte-
nance medium is referred to as MM. At day 0 the cells were
plated at*10 neurospheres per well (each well containing a
12-mm glass coverslip coated with the different polymer film
treatment groups) in a 24-well plate in 500 mL of differenti-
ation medium (a proprietary medium, Bulletkit; Lonza)
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further supplemented with 20 ng/mL recombinant human
brain-derived neurotrophic factor (BDNF; Sigma-Aldrich).
The differentiation medium is referred to as DM. The poly-
mer film treatment groups included poly(CPTEG), 75:25
CPTEG:CPH, 50:50 CPTEG:CPH, and 25:75 CPTEG:CPH
(blank or 1% laminin loaded in the polymer film) at a
polymer coating of 1.5mg/coverslip. The control treatment
groups included laminin-coated coverslips incubated either
in DM with BDNF as a positive control (laminin DM) or in
MM as a negative control (laminin MM). Cultures with the
different treatment groups were maintained for 7 days.
Culture media were replenished with 350 mL of fresh media
at days 3 and 5.
Immunocytochemistry on hNPCs
After the 7-day incubation period, the hNPCs were im-
munolabeled. The coverslips containing the cells were rinsed
in 0.1M phosphate (PO4) buffer and then fixed with 4%
paraformaldehyde in 0.1M PO4 buffer for 30min. After fix-
ation, the cells were washed in PBS and then incubated with
the primary TUJ1 antibody (mouse monoclonal IgG; R&D
Systems) diluted (1:200) in blocking solution (0.4% BSA
[Sigma-Aldrich], 0.2% Triton X-100 [Fisher Scientific], and
2.5% normal goat serum [Jackson ImmunoResearch, Inc.])
overnight at 4C. The next day the cells were rinsed in PBS
and incubated with a goat anti-mouse secondary antibody
(Cy5-conjugated; Jackson ImmunoResearch, Inc.) diluted
(1:500) in the same blocking solution for 2 h. Cells on the
coverslips were rinsed in PBS and then incubated with a
Alexa Fluor 488 (AF488)–conjugated primary microtubule-
associated protein 2B (MAP2B) antibody (mouse monoclonal
IgG; BD Pharmingen) and a Cy3-conjugated primary glial
fibrillary acidic protein (GFAP) antibody (mouse monoclonal
IgG; Sigma-Aldrich) diluted in the blocking solution (1:18
and 1:400, respectively) overnight at 4C. The next day, cells
on the coverslips were rinsed in PBS. Then, nuclei were
counterstained with 1 mM 4¢,6-diamidino-2-phenylindole
diactate (DAPI) and the preparations were mounted on mi-
croscope slides with Gel Mount (Fisher Scientific) for fluo-
rescence microscopy analysis.
Microscopy, image acquisition, and data analysis
Epifluorescent microscopy was carried out with an up-
right fluorescence microscope (Nikon Microphot FXA;
Nikon, Inc.) equipped with a Retiga 2000R digital camera
controlled by QCapture software (QImaging). A minimum of
eight images with an average of 222 cells per image was
taken per fluorochrome per treatment group using a 20·
objective. ImageJ software (NIH, Bethesda, MD) was used to
analyze the microscopy images. To calculate the percentage
of immunoreactive cells, the number of cells immunoreactive
for each antibody was divided by the total number of cells
(DAPI-stained nuclei).
Statistical analysis
JMP software (SAS Institute) was used to make compari-
sons between multiple different treatments using a model
ANOVA with Tukey’s HSD as indicated by letters above
each bar. Differing letters represent difference between
treatments in Figures 2, 3, and 5 and Supplementary Figures
S1 and S2 (Supplementary Data are available online at
www.liebertonline.com/tea). In Figure 2A comparisons be-
tween each treatment and the control were made using the
Student’s t-test and indicated by an asterisk above the bars.
Results
Polymer characterization and protein release
The NMR and GPC characterization indicated that poly-
mer molecular weight, structure, and composition were as
intended and in agreement with previous studies.24,34,36
High-throughput laminin release studies from CPTEG:CPH
copolymer films (Fig. 1) were carried out because laminin is
an adhesion protein for cellular binding to substrates.37–39
Figure 1 shows that laminin was released in a controlled
manner over time as a function of polymer chemistry. By
increasing the content of the less hydrophobic CPTEG in the
copolymer, protein release rates were higher.
Polyanhydride libraries are biocompatible and induce
low levels of immune response
To test the toxicity of polyanhydride film libraries to pri-
mary cells, dendritic cells (DCs), which are professional an-
tigen presenting cells of the immune system, were incubated
with varying concentrations of 50:50 CPTEG:CPH copolymer
films and cell viability was examined by the MTT assay (Fig.
2A). All polymer concentrations below 16.9mg/mL resulted
in no statistical difference for the cell viability compared to
the NP-positive control. This result signifies that a wide
range of polymer coating or scaffold thicknesses could be
utilized with this system.
To test the effects of the film libraries on induction of an
immune response, DCs were incubated on the polymer films
for 2 days. Supernatants were analyzed for secreted cyto-
kines, TNF-a, IL-6, and IL-12p40, and cells were stained for
expression of cell surface markers, MHC I, MHC II, CD40,
and CD86, and analyzed by flow cytometry. Secretion of
these cytokines and expression of these cell surface markers
are indicators of immune activation and DC maturation.40
The results showed that the CPTEG:CPH polymer films
FIG. 1. Cumulative mass fraction release of laminin from
CPTEG:CPH copolymer film libraries. The CPTEG-rich films
released laminin most rapidly, whereas CPH-rich films re-
leased laminin the slowest. Error bars represent standard
deviation and six independent experiments were carried out.
CPH, 1,6-bis( p-carboxyphenoxy)hexane; CPTEG, 1,8-bis( p-
carboxyphenoxy)-3,6-dioxaoctane.
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cause DCs to downregulate cytokine secretion (IL-12p40 and
IL-6) compared to the NP control (Fig. 2B). TNF-a was below
detection limits for all treatments except LPS. Additionally,
low levels of cell surface marker expression were observed
(Fig. 2C). Both cell marker expression and cytokine produc-
tion appeared to be modulated in a chemistry-dependent
manner. These findings suggest that there may be an optimal
copolymer composition, such as 50:50 CPTEG:CPH, that is
capable of achieving the lowest level of immune stimulation.
Adhesion of hNPCs to the polymer library
is controlled by polymer chemistry
hNPCs were incubated for 7 days with the polymer film
library and investigated for their ability to adhere and dif-
ferentiate. Initial studies evaluated the adhesion of hNPCs
on blank or laminin-encapsulated polymer film libraries,
including poly(CPTEG), 75:25 CPTEG:CPH, 50:50 CPTEG:
CPH, and 25:75 CPTEG:CPH. The results indicated that
blank polymer films provided a nonfouling background
preventing cellular adhesion with all polymer chemistries
(data not shown). However, when laminin was encapsulated
into the polymer films, cellular adhesion was restored in for
CPH-rich polymer film chemistries (data not shown). These
results indicate that the biological functionality of laminin
was preserved upon encapsulation into the polymer films. In
addition, CPTEG-rich polymer chemistries resulted in mini-
mal cellular adhesion (even with laminin encapsulated into
the polymer) (data not shown), which is likely a result of the
ethylene glycol1,41 incorporated into the polymer backbone.
Differentiation of hNPCs is controlled
by polymer chemistry
The three polymer film chemistries with adequate cellular
adhesion (75:25 CPTEG:CPH, 50:50 CPTEG:CPH, and 25:75
CPTEG:CPH) were studied for their influence on hNPC
differentiation. Figure 3 suggests that film chemistry con-
FIG. 2. Biocompatibility and immune stimulation capabilities of CPTEG:CPH polymer films. (A) Viability of DCs incubated
with 50:50 CPTEG:CPH films at varying concentrations, (B) cytokine production (TNF-a was below detection limits for all
treatments except LPS), and (C) cell marker expression of DCs incubated with polymer film libraries. Average IL-12p40, IL-6,
and TNF-a concentrations for cells stimulated with LPS were 55,900, 101,500, and 4600 pg/mL, respectively. In (A), asterisks
indicate statistical significance from the NP control group; in (B) and (C), letters indicate statistical significance between
treatments for each cytokine or cell marker, respectively. Three independent experiments were carried out with replicates of
two in each experiment, and error bars represent standard error of the mean. DCs, dendritic cells; LPS, lipopolysaccharide;
NP, no polymer.
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trolled the differentiation of hNPCs with 50:50 CPETG:CPH
resulting in the lowest percentage of hNPCs immunoreactive
for MAP2B, a marker of immature neurons. The other two
chemistries resulted in significantly higher percentages of
MAP2B-immunoreactive cells. The percentages of cells im-
munoreactive for beta III tubulin (TUJ1, marker of develop-
ing neurons) or GFAP (astrocyte marker) were increased in
the presence of CPTEG-rich chemistries. The data in Figure 3
suggest that 75:25 CPTEG:CPH polymer films enhance the
most hNPC differentiation into both astrocytes and neurons
compared with other film treatments and control treatments
(positive control: laminin-coated glass coverslip with NP film
in differentiation media [laminin DM]; negative control:
laminin-coated glass coverslip with NP film in maintenance
media [laminin MM]).
Supplementary Figure S1 presents the percentages of
hNPCs that were immunostained for MAP2B (Supplemen-
tary Fig. S1A) and TUJ1 (Supplementary Fig. S1B), respec-
tively. The data in Supplementary Figure S1A suggest that
higher fraction of hNPCs were undergoing neuronal differ-
entiation when they were incubated on CPTEG-rich polymer
films (75:25 and 50:50 CPTEG:CPH) than on 25:75
FIG. 3. Percentage of hNPCs
displaying neuronal (MAP2B
and TUJ1) or glial (GFAP)
differentiation. The CPTEG-
rich films best enhanced hNPC
differentiation. Letters indicate
statistical significance between
treatments for each cell
marker, eight different images
were analyzed with an average
of 222 cells per image, and
error bars represent standard
deviation. GFAP, glial fibrillary
acidic protein; hNPCs, human
neural stem/progenitor
cells; MAP2B, microtubule-
associated protein 2B.
FIG. 4. Representative epi-
fluorescent images of hNPCs
stained for DAPI (blue, column
1), MAP2B (AF488 green,
column 2), TUJ1 (Cy5 red,
column 3), and GFAP (Cy3
yellow, column 4), after incu-
bation with 25:75 CPTEG:CPH,
50:50 CPTEG:CPH, 75:25
CPTEG:CPH, laminin-coated
coverslip in DM (positive con-
trol, Laminin DM), and
laminin-coated coverslip in MM
(negative control, Laminin
MM). The hNPCs readily
adhered to CPH-rich polymer
films and strongly expressed
differentiation markers. DAPI,
4¢,6-diamidino-2-phenylindole
diactate; DM, differentiation
medium; MM, maintenance
medium. Color images available
online at www.liebertonline
.com/tea
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CPTEG:CPH films. In addition, the percentage of cells im-
munoreactive for MAP2B in both cell body and neurites was
higher when the cells were cultured on 75:25 CPTEG:CPH
films than CPH-rich polymer films. Supplementary Figure
S1B also demonstrates increasing trends for the percentages
of TUJ1-positive hNPCs (immunolabeled in both cell body
and neurites) when incubated with increasing CPTEG con-
tent in the polymer film.
Images of each treatment group and marker can be ob-
served in Figure 4 and corroborate the data presented in
Figure 3. By quadruple labeling the hNPCs (DAPI-nucleus,
AF488-MAP2B, Cy5-TUJ1, and Cy3-GFAP), double-positive
cell populations for the differentiation markers were assessed
as shown in Figure 5. Figure 5A indicates that cells immu-
noreactive for MAP2B are also largely positive for TUJ1 or
GFAP, especially when incubated on CPH-rich polymer
films. However, cells immunoreactive for TUJ1 or GFAP are
less positive for each other, but follow the same chemistry-
dependent trend (Fig. 5B, C). The hNPC populations positive
for MAP2B appeared to be more influenced by polymer film
chemistry in their immunoreactivities for TUJ1 or GFAP than
populations positive for TUJ1 or GFAP, which only resulted
in chemistry-dependent trends for colabeling with GFAP or
TUJ1, respectively. When examining the entire hNPC pop-
ulation (based upon DAPI count) (Supplementary Fig. S2),
the data indicate an opposite chemistry trend with CPTEG-
rich polymer films influencing the most double-positive ex-
pression of cells for TUJ1 and GFAP, and GFAP and MAP2B.
In contrast, double-positive cells for both neuronal makers,
TUJ1 and MAP2B, trended toward CPH-rich chemistries.
Discussion
Many current approaches to tissue engineering scaffolds
or implant coatings have focused on the use of surface
functionalization or controlled release of biological signals
to promote cellular adhesion, growth, vascularization, dif-
ferentiation, and so on, and/or to inhibit the growth and
viability of infectious microorganisms.1,2 In this regard,
CPTEG:CPH copolymers represent a biodegradable delivery
system capable of both controlled release and surface func-
tionalization. In this work these copolymers were demon-
strated to release laminin in a chemistry-dependent manner,
which was a strong function of the hydrophobicity of the
polymer film (Fig. 1). All the polyanhydride chemistries
tested in this work demonstrated the ability to preserve the
FIG. 5. CPH-rich chemistries
resulted in the most double-
positive hNPC populations for
MAP2B +TUJ1, MAP2B+GFAP,
TUJ1 +GFAP, and GFAP +TUJ1.
(A) The percentage of MAP2B +
hNPCs also positive for TUJ1 or
GFAP; (B) the percentage of
TUJ1 + hNPCs also positive for
MAP2B or GFAP; and (C) the
percentage of GFAP + hNPCs also
positive for MAP2B or TUJ1.
Letters indicate statistical signifi-
cance between treatments for each
marker, eight different images
were analyzed with an average of
200 cells per image, and error bars
represent standard deviation.
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functionality of laminin. This is consistent with other work
from our laboratory on the protein stabilization capabilities
of this amphiphilic polymer system.11,17,19,21,24 In those
studies, the stabilization of fragile recombinant proteins as
well as more robust globular proteins was shown to be
strongly dependent upon polymer chemistry, with the am-
phiphilic chemistries providing the best environment for
preservation of protein activity (and structure). Recently,
Carrillo-Conde et al. demonstrated that CPTEG:CPH nano-
particles can be functionalized with carbohydrates with an
eye toward targeting DCs for immune activation.12 That
approach could be applied to functionalize the polymer films
in this work for promoting cell-specific adhesion and growth
and/or for reducing bacterial adhesion and growth. Bacter-
icidal activity of a tissue engineering scaffold or implant
coating would be a key advancement for reducing implant
infections, especially intracellular bacteria, which cannot be
cleared by antibiotics and pose a threat to implant viability.1
Biocompatibility and immune acceptance, specifically
low inflammatory responses, of the implant by the host of-
ten dictate acceptance of the implant and in vivo viability.
Materials capable of inducing low immune recognition
would be ideal candidates for tissue engineering applica-
tions as coatings to noninflammatory implants or implants
themselves. DCs were used to study the effect of
CPTEG:CPH polymer films on cellular toxicity, expression of
surface markers responsible for DC maturation and anti-
gen presentation (MHC II, MHC I, CD86, and CD40), and
secretion of both inflammatory and immune activating
cytokines (TNF-a, IL-6, and IL-12p40). This work has dem-
onstrated that the CPTEG:CPH polymer film system modu-
lated the immune response of DCs in a chemistry-dependent
manner (Fig. 2). Moderate to low CPTEG-containing copol-
ymer compositions demonstrated simulation levels no
higher than the negative (NP) control group. This indicates
that these films could be stealth-like to the immune system.
Further, all the chemistries studied maintained background
levels or decreased production of the pro-inflammatory cy-
tokines TNF-a and IL-6 (Fig. 2B). These data suggest that
these films may elicit weak inflammatory responses in vivo.
In other related work from our laboratories, when nano-
particles made of these polymers were administered intra-
nasally or subcutaneously, very low levels of inflammation
were observed.42 Since nanoparticles can be phagocytosed, it
is reasonable to expect that the same chemistry in non-
phagocytic geometries (i.e., film, coating, and scaffold)
would elicit even lower levels of inflammation similar to
what was observed in vitro.23
Stealth-like behavior enabling protection from immune
activation and clearance by the immune system are impor-
tant characteristics for implant or scaffold acceptance and
tissue integration. However, it is also important that cell
survival, adhesion, and differentiation within the polymer
are conducive for cellular integration and tissue regenera-
tion. As shown in Figure 3A, the CPTEG:CPH films were
biocompatible at concentrations 30-fold higher than those
administered in vivo.16,43 Adhesion and differentiation of
hNPCs was also enabled by this system in a chemistry-
dependent manner. Adhesion was not favored for the
CPTEG-rich chemistries due to the ethylene glycol content in
the backbone of poly(CPTEG). This is consistent with other
studies in which low protein adsorption was observed on
the surface of microparticles composed of CPTEG-rich
chemistries.10
Cellular differentiation is also influenced by chemistry
with CPTEG-rich compositions influencing the most overall
expression of cells positive for neuronal markers (Figs. 3 and
4). This suggests that 75:25 CPTEG:CPH has the ability to
enhance differentiation of hNPCs into neurons and glial cells.
In addition, 50:50 CPTEG:CPH may also be able to promote
neural differentiation as indicated by the higher fraction of
hNPC cell bodies immunoreactive for MAP2B (Supplemen-
tary Fig. S1A). Further, the double-positive phenotype of the
hNPCs suggests that all treatments, except Laminin MM,
result in a TUJ1-positive cell population that is largely
MAP2B positive (*100%) (Fig. 5); however, the MAP2B-
positive population reveals a smaller population positive for
TUJ1 (50–80%). It has been reported that TUJ1 is an axonal
marker for immunolabeling maturing neurons44,45 and
mammalian MAPs are specifically localized in dendrites and
play a role in microtubule-stabilization and possibly sup-
porting dendritic elongation.46,47 As such, immunolabeling
with these two antibodies allows identification of different
compartments within neurons (TUJ1: soma and developing
axons; MAP2B: soma and developing dendrites). Thus, the
variation observed between these two double-positive pop-
ulations suggests differential maturation of the neuronal
processes (e.g., dendrites vs. axons). Additional phenotypes
of hNPC populations double positive for both neural (TUJ1
or MAP2B) and glial (GFAP) phenotypes can be identified in
Figure 5 as well. During the differentiation process, it is
possible that exogenous factors may have induced an ‘‘in-
determinate’’ differentiation phenotype characterized by si-
multaneous expression of glial and neuronal markers
(MAP2B and GFAP or TUJ1 and GFAP).48
This work demonstrates the capabilities of CPTEG:CPH
polymer films to control cellular adhesion and differentiation
in a chemistry-dependent manner while providing a system
capable of releasing biologically relevant proteins for further
controlling cellular behavior. By employing a combinatorial
platform approach, these protein–material and cell–material
interactions were rapidly screened, which will facilitate the
rational design of tissue engineering systems composed of
biodegradable polyanhydrides.
Conclusions
Amphiphilic polyanhydride films provide a biologically
tunable environment capable of overcoming many of the
challenges associated with tissue engineering constructs.
They were capable of preserving protein structure while
controlling protein release, which is integral for dictating
cellular behavior (adhesion, differentiation, etc.). The poly-
mer films also demonstrated immune stealth characteristics
indicated by background level stimulation of DCs and low
inflammatory signaling. These attributes are important for
implant host acceptance, whereas other properties promot-
ing tissue-specific cell interactions are vital for implant inte-
gration into the host. This amphiphilic polymer film system
also demonstrated the capability to promote and control
hNPC adhesion and differentiation. A copolymer containing
50% CPTEG and 50% CPH may present optimal properties
for neural tissue engineering with hNPCs by limiting im-
mune recognition while providing a conducible environment
AMPHIPHILIC FILMS FOR NEURAL TISSUE ENGINEERING 2539
for cellular adhesion and differentiation. These amphiphilic
polymers may provide an excellent platform technology for
tissue engineering constructs.
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